DOCSLIB.ORG

International and Lung Disease Journal of Tuberculosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
International and Lung Disease Journal of Tuberculosis 50TH WorlD Conference on luNg HEAlTH Of the International Union AgainsT Tuberculosis and Lung Disease (The Union) VOLUME 23 PAGES S1–S645 ISSN 1027 3719 NUMBER 10 NOVEMBER 2019 The SUPPLEMENT 1 International Journal of Tuberculosis and Lung Disease The Official Journal of the International Union Against Tuberculosis and Lung Disease ABSTRACT BOOK 50th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union) HYDERABAD • INDIA 30 OCTOBER – 02 NOVEMBER 2019 TABlE Of Contents The International Journal of Tuberculosis and Lung Disease SUPPLEMENT 2 VOLUME 22 NUMBER 11 NOVEMBER 2019 The Union would like to thank the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/JATA) for their support in publishing the Abstract Book for the 50th Union World Conference on Lung Health. SYMPOSIA: S16 SP-16-C1 Fulfilling Commitments from the UN High Level Meeting on Tuberculosis: Programmatic THURSDAY, 31 OCTOBER 2019 Strategies for Taking Tuberculosis Preventive S1 SP-01-E3 Leading change makers to action: Treatment to Scale TB in displaced persons in complex emergencies S17 SP-17-A2 The way forward for TB vaccines S2 SP-02-B2 Advancing observational research from S18 SP-18-B2 Reducing deaths from tuberculous MDR-TB treatment cohorts: data and methods, meningitis challenges and opportunities S19 SP-19-B7 Asthma: an emerging threat to health S3 SP-03-C1 Science and action on subclinical TB: across the life course progress in understanding, diagnosis, treatment and policy S19 SP-20-B4 Therapeutic TB trials in children: improving knowledge and access S4 SP-04-A3 Xpert MTB/RIF ULTRA transitioning: where are we? S21 SP-21-B1 Early scale-up and evaluation of TB case finding and systematic screening using S5 SP-05-C10 The wheels keep on turning for digital chest radiography and computer-aided specimen referrals diagnosis in Africa and Asia S6 SP-06-C4 Regional child and adolescent TB S22 SP-22-C8 Taking TB diagnostics to the fields: initiatives to promote efforts towards a TB improving access by extending advanced point- disease-free generation of-care (PoC) testing to rural communities S7 SP-07-C11 Leveraging a community-of-practice S22 SP-23-F3 Assessing the burden and impact of learning model to strengthen TB and HIV data zoonotic tuberculosis quality and use for programmatic action S23 SP-24-C1 Scaling up TB preventive treatment: S8 SP-08-B7 Lung health and well-being after TB considerations on target populations and S8 SP-09-E3 The right to TB treatment and care to diagnostic approaches end the emergency S24 SP-25-A1 The surprising role of adipose tissue at S9 SP-10-A3 Increasing availability of DST diagnostic: the intersection of TB infection and immunity need for thinking inside the box for a better, S25 SP-26-A2 Leadership, science and action to cost-effective and sustainable network advance new tools to end the TB emergency S11 SP-11-B2 Making the switch: country-level experience with programmatic or OR implementation of fully oral, shorter DR-TB SYMPOSIA: regimens FRIDAY, 1 NOVEMBER 2019 S12 SP-12-C4 Moving towards child-friendly strategies S27 SP-27-B2 From shorter to short: progress towards for paediatric TB laboratory-based diagnosis six-month all-oral treatment regimens for MDR-TB S13 SP-13-C3 Unanswered questions about how best to S28 SP-28-A3 Modified shorter treatment regimen: treat MDR-TB patients: evidence from the end TB using evidence, capacity building and public observational study health approach to build sustainable and efficient S14 SP-14-C1 Sharpening our focus: treating recent MDR-TB care TB infection in healthcare workers in TB-endemic S29 SP-29-C6 TB preventive therapy in pregnant women: countries is it safe and how should we implement it? S15 SP-15-B8 Tobacco control interventions should be S30 SP-30-C12 Indian policies to stop industry interference, implemented in TB control programmes and their potential for sub-national levels globally S31 SP-31-C7 Ending the socio-economic emergency S49 SP-53-C6 Confronting the crisis: emerging research for TB-affected households by improving social in maternal-child TB protection coverage S50 SP-54-C1 Tuberculosis Preventive Treatment (TPT): S32 SP-32-F4 Accelerating control of zTB in low- and implementation, scale-up and realities middle-income countries S51 SP-55-C7 Putting evidence into action: integrating S33 SP-33-B6 The importance of tackling comorbidities mental health treatment to end the TB emergency to reach the End TB goals S52 SP-56-E1 Shifting the gender paradigm in the TB S34 SP-34-E3 Coercion in TB: human rights and ethical response: women’s voices concerns for the use of coercion in the TB response S53 SP-57-B1 Lessons learned from national TBPSs using S34 SP-35-C11 Action on the ground: using the ECHO culture and Xpert MTB/RIF: TB or not TB? virtual community of practice model to promote S54 SP-58-C8 Strategic initiative for finding the missing health equity by building local health workforce people with TB capacity S54 SP-59-E1 Amplifying the voices of the TB-affected S35 SP-36-E1 Implementing national level accountability community through OneImpact: a mobile for the UN HLM on TB: key recommendations and community-based monitoring (CBM) technology opportunities system S36 SP-37-C4 Ending paediatric TB through action: S55 SP-60-C8 TB-HIV care cascade analysis to inform operationalising shorter TPT regimens in children programmatic management and quality service S37 SP-38-C8 MATCH: access analysis and diagnostic delivery network optimisation S56 SP-61-C9 Making informed and smart choices: S38 SP-40-C7 Addressing mental health and substance evidence-based optimisation of national strategies to use disorders in TB: a must for people-centred TB end TB care S57 SP-62-C4 Improving access to TB care for children: S38 SP-41-B1 Saving lives: Improving access to TB LAM successful approaches and upcoming opportunities testing S57 SP-63-B7 Fighting to breathe: living with asthma, S39 SP-42-D1 Food for thought: impact of malnutrition COPD and chronic respiratory diseases, and how to on the TB epidemic end the silence S40 SP-43-A3 New and repurposed drug resistance S58 SP-64-D8 Modelling to support ending the emergence: current status and prevention strategies emergency: science, leadership, action S41 SP-44-C3 Sustainable models for strengthening S59 SP-65-C8 Reaching the missing men: strategies to pharmacovigilance of TB medicines and diagnostics: improve men’s access to TB diagnosis and treatment global and regional perspectives and country S60 SP-66-E2 Taking action: addressing the oft-neglected examples stigma of TB within the healthcare setting S42 SP-45-B2 MDR-TB operational research on oral S61 SP-67-D1 Using TBPSs to catalyse the response regimens: spectrum of approaches and next steps towards ending TB in the African region S43 SP-46-C9 Ready yet? The implications of donor financing transition on national TB programmes S44 SP-47-C1 Accelerating the curve: TB prevention through short rifamycin-based regimens for hard-to- ABSTRACT PRESENTATIONS reach groups THURSDAY, 31 OCTOBER 2019 S45 SP-48-E2 Mobilising youth as agents of change for a TB-free world ORAL ABSTRACT SESSIONS S46 SP-49-C8 It’s time to scale up: progress in rolling out TB contact investigation in high-burden S63 OA01 Will we get there? Challenges to ending settings tuberculosis S47 SP-50-C12 How to protect children from tobacco S67 OA02 Tuberculosis infection: from latent to industry interference: a review of treaties, strategies, eliminated challenges and progress S72 OA03 Clinical investigation for tuberculosis S77 OA04 Anti-tuberculosis treatment in patients with SYMPOSIA: comorbidities SATURDAY, 2 NOVEMBER 2019 S80 OA05 Epidemiology of tobacco use and effects and some quick facts behind tobacco farming S48 SP-51-D6 Preventive therapy: time to roll out population-based treatment to reach the goal of TB S84 OA06 Multidrug-resistant tuberculosis: pearls and elimination? wisdom S48 SP-52-B2 Anticipating changes in care for DR-TB S89 OA07 Highlights from the laboratory S93 OA08 Has MPOWER empowered nations to tackle S232 PS-11-C2 Supporting patients for better TB tobacco epidemic? treatment outcomes S96 OA09 Diagnosis, screening, prediction of disease in S239 PS-12-C1 TPT: How can we increase uptake? people living with human immunodeficiency virus S243 PS-13-C8 World tour: innovations in finding and for diabetes “missing persons” with TB S101 OA10 National policymaking to achieve HlM & end S249 PS-14-C10 They‘re out there somewhere: TB case TB goals finding strategies S105 OA11 TB training and education initiatives to build capacity and improve outcomes SHORT ORAL ABSTRACT SESSIONS ABSTRACT PRESENTATIONS S110 SOA-01-B1 Thinking beyond current diagnostics FRIDAY, 1 NOVEMBER 2019 S115 SOA-02-D1 The prevention cascade: prevent, treat, retain ORAL ABSTRACT SESSIONS S122 SOA-03-C7 Person-centred care: a spectrum of S255 OA-12-C8 Active TB case finding: one size does not activities truly fit all: part 2 S127 SOA-04-C1 TPT: old and new regimens S259 OA-13-B1 Genotyping: state of the art S134 SOA-05-E1 Patient detection and care innovations S262 OA-14-C1 Towards TB elimination: the missing 30 million LTBI treatments S140 SOA-06-D2 Defining the TB epidemic in children to inform action S268 OA-15-A3 Rapid genetic TB testing: performance and quality S146 SOA-08-C3 Different approaches to combating DR-TB S271 OA-17-C3 MDR-TB treatment outcomes S151 SOA-09-D9 Achieving UHC: understanding and eliminating catastrophic patient costs in TB care
Load more

Recommended publications
  • First East and Southern Africa Regional Symposium Improving Menstrual Health Management for Adolescent Girls and Women
    First East and Southern Africa Regional Symposium Improving Menstrual Health Management for Adolescent Girls and Women 28-29 May 2018 Johannesburg, South Africa FINAL REPORT Acknowledgements The Department in the Presidency Responsible for Women and UNFPA East and Southern Africa wish to warmly acknowledge the generous support of the various organizations that provided financial assistance and/or other forms of support for the Symposium: Celebrating: 2 Abbreviations CSE Comprehensive Sexuality Education DfID Department for International Development DRC Democratic Republic of the Congo ESA East and Southern Africa ESARO East and Southern Africa Regional Office IASC Inter-Agency Standing Committee ICW International Community for Women Living with HIV IRC International Rescue Committee KZN KwaZulu-Natal M&E Monitoring and Evaluation MEL Monitoring, Evaluation and Learning MHH Menstrual Hygiene and Health MHM Menstrual Health Management PMA Performance Monitoring and Accountability PSI Population Services International RSS Refugee Social Services SDGs Sustainable Development Goals SIF Supplies, Information, Facilities STIs Sexually Transmitted Infections SRHR Sexual and Reproductive Health and Rights TIRZ Transgender Intersex Rising Zimbabwe UNESCO United Nations Educational, Scientific and Cultural Organization UNFPA United Nations Population Fund UNICEF United Nations Children’s Fund UN WOMEN United Nations Entity for Gender Equality and the Empowerment of Women WASH Water, Sanitation and Hygiene WHO World Health Organization © UNFPA ESARO/Sven
    [Show full text]
  • Annual Report 2017 Contents Message from Leadership
    annual report 2017 Contents message from leadership . 2 our history . 4 our values . 6 where we work . 8 hiv/aids . 10 malaria . 18 maternal, newborn, and reproductive health . 24 essential medicines for diarrhea and pneumonia . 30 vaccines . 36 nutrition . 42 tuberculosis . 48 hepatitis . 52 cancer . 58 health systems strengthening . 62 financials . 70 acknowledgements . 73 our leadership team and board of directors . 74 image, front cover: a mother waits to have her child immunized at a clinic kano, nigeria image, opposite: a mother who received antenatal care and delivered her son at the barau diko hospital kaduna, nigeria message from leadership During the past year CHAI has renewed its in a number of high-endemic areas and treat it strategy and set important goals for the future. A effectively when it does occur. platform has been established from which we can In places where we work, over 40 percent less accomplish profound humanitarian goals over the women will die in childbirth and over 40 percent next five to ten years. We have extraordinary people, fewer infants will die in their first weeks of life. a global reach, a unique body of knowledge and Certain preventable and curable cancers will no capabilities, and close and trusted relationships longer be “death sentences” in many developing with governments, local communities, global countries as we help make prevention and cures organizations, other NGOs and suppliers of health affordable and available. With our help, within the products and services. We have the track record to next 10 years, a number of the countries where we accomplish our goals, and an excellent board of work will set up finance systems, educate enough directors to help guide and support our efforts.
    [Show full text]
  • First East and Southern Africa Regional Symposium Improving Menstrual Health Management for Adolescent Girls and Women
    First East and Southern Africa Regional Symposium Improving Menstrual Health Management for Adolescent Girls and Women 28-29 May 2018 Johannesburg, South Africa FINAL REPORT Acknowledgements The Department in the Presidency Responsible for Women and UNFPA East and Southern Africa wish to warmly acknowledge the generous support of the various organizations that provided financial assistance and/or other forms of support for the Symposium: Celebrating: 2 Abbreviations CSE Comprehensive Sexuality Education DfID Department for International Development DRC Democratic Republic of the Congo ESA East and Southern Africa ESARO East and Southern Africa Regional Office IASC Inter-Agency Standing Committee ICW International Community for Women Living with HIV IRC International Rescue Committee KZN KwaZulu-Natal M&E Monitoring and Evaluation MEL Monitoring, Evaluation and Learning MHH Menstrual Hygiene and Health MHM Menstrual Health Management PMA Performance Monitoring and Accountability PSI Population Services International RSS Refugee Social Services SDGs Sustainable Development Goals SIF Supplies, Information, Facilities STIs Sexually Transmitted Infections SRHR Sexual and Reproductive Health and Rights TIRZ Transgender Intersex Rising Zimbabwe UNESCO United Nations Educational, Scientific and Cultural Organization UNFPA United Nations Population Fund UNICEF United Nations Children’s Fund UN WOMEN United Nations Entity for Gender Equality and the Empowerment of Women WASH Water, Sanitation and Hygiene WHO World Health Organization © UNFPA ESARO/Sven
    [Show full text]
  • Tuberculosis Must Fall! Tuberculosis INTERNATIONAL DEVELOPMENT in FOCUS in DEVELOPMENT INTERNATIONAL
    Tuberculosis Must Fall! Tuberculosis Tuberculosis Must Fall! A Multisector Partnership to Address TB in Southern Africa’s Mining Sector Osewe and Kistnasamy Osewe Patrick L. Osewe and Barry Kistnasamy INTERNATIONAL DEVELOPMENT IN FOCUS INTERNATIONAL INTERNATIONAL DEVELOPMENT IN FOCUS Tuberculosis Must Fall! A Multisector Partnership to Address TB in Southern Africa’s Mining Sector Patrick L. Osewe and Barry Kistnasamy © 2018 International Bank for Reconstruction and Development / The World Bank 1818 H Street NW, Washington, DC 20433 Telephone: 202-473-1000; Internet: www.worldbank.org Some rights reserved 1 2 3 4 21 20 19 18 Books in this series are published to communicate the results of Bank research, analysis, and operational experience with the least possible delay. The extent of language editing varies from book to book. This work is a product of the staff of The World Bank with external contributions. The findings, inter- pretations, and conclusions expressed in this work do not necessarily reflect the views of The World Bank, its Board of Executive Directors, or the governments they represent. The World Bank does not guarantee the accuracy of the data included in this work. The boundaries, colors, denominations, and other informa- tion shown on any map in this work do not imply any judgment on the part of The World Bank concerning the legal status of any territory or the endorsement or acceptance of such boundaries. Nothing herein shall constitute or be considered to be a limitation upon or waiver of the privileges and immunities of The World Bank, all of which are specifically reserved. Rights and Permissions This work is available under the Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO) http:// creativecommons.org/licenses/by/3.0/igo.
    [Show full text]
  • A Systematic Approach to Improve Rational Medicine Use in Eswatini
    A systematic approach to improve rational medicine use in Eswatini Nondumiso Beauty Queeneth Ncube Student number: 3616957 Submitted in fulfilment of the requirements for the degree PhD in the School of Public Health, Community and Health Sciences Faculty, University of the Western Cape Supervisor: Dr. Hazel Anne Bradley Co-Supervisors: Prof Helen Schneider and Prof Richard Laing i http://etd.uwc.ac.za/ Abstract Studies on rational medicine use (RMU) have mainly focused on identifying, quantifying, and addressing irrational use without exploring reasons behind this irrational use. In addition, minimal work has been conducted on irrational use of medicines in the context of the growing burden of non-communicable diseases (NCDs). This PhD research examined medicine use in Eswatini, (previously Swaziland) between April 2017 and March 2019, with a focus on prescribing practices linked to specific diagnoses. It further explored factors influencing RMU, which included testing the effects of a short intervention - prescription audit and feedback coupled with small group education - on prescribing practices in health facilities. This intervention study employed a mixed methods approach with both quantitative and qualitative components. RMU was assessed based on the World Health Organization/ International Network for the Rational Use of Drugs (WHO/INRUD) prescribing indicators at three time points: baseline, post intervention and post follow-up. Baseline results were used to design an unblinded intervention in 32 health facilities, randomly allocated to intervention (16) and control (16) arms. The intervention, prescription audit coupled with small group education, was designed based on baseline findings. Percentage of prescriptions with at least one antibiotic was used to allocate facilities to intervention and control arms.
    [Show full text]